This site uses cookies from Google and other third parties to deliver its services, to personalise adverts and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies. Read our policy.

Skip to main content
Skip to navigation

Publishing
Education
Membership

Search our site

Close menu

Home
News
Coronavirus
Research
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Register

Home
News
Coronavirus
Research
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Register
More navigation items

Sitewide message

Book your free demo and find out what else Mya 4 from Radleys can do

Get your FREE white paper on 2D-LC for superior analysis of polymers

Download your FREE white paper on green analytical chemistry

Subscribe to this podcast series

Subscribe viaRSS Feed Listen onApple Podcasts Listen onGoogle Podcasts Listen onSpotify

Subscribe to this podcast series

Subscribe viaRSS Feed Listen onApple Podcasts Listen onGoogle Podcasts Listen onSpotify

Subscribe to this podcast series

Subscribe viaRSS Feed Listen onApple Podcasts Listen onGoogle Podcasts Listen onSpotify

All Emma Walmsley articles

Business
GSK stops over 30 research programmes to prioritise innovation

2017-08-04T14:05:00Z

New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects

Subscribe
Advertise
Topics
Issues
Contributors

Help
Contact
Privacy
Terms of use
Accessibility
Permissions
MB_0_Reg

Our mission
News and events
Campaigns
Awards and funding
Global challenges
Support our work

All Emma Walmsley articles

GSK stops over 30 research programmes to prioritise innovation